# Aloe Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aloe-therapeutics

- Industry: Biotechnology
- Headquarters: US
- Website: www.aloetherapeutics.org/
- Total disclosed funding: $0.1M
- Latest round: Seed (Apr 8, 2024)
- Investors on record: 1

## About

Based in the US, Aloe Therapeutics Inc., operates as a healthcare technology company focused on developing cancer treatments. Their main area of interest is a local immunotherapy called allo-immunotherapy (AIM) designed to be implanted near tumors. In April 2024, Aloe Therapeutics Inc., raised USD 0.1 million in seed funding from TEDCO.

The company offers cancer therapies, specifically focused on developing groundbreaking approaches in immunotherapy to transform the treatment landscape for solid tumors.

The company’s therapy is designed to minimize systemic or overlapping toxicity with conventional cancer therapies.

## Funding rounds

- Seed, Apr 8, 2024, $0.1M — TEDCO

## Investors

- TEDCO (https://capitalatlas.ai/funds/tedco) — Seed